Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 213239, 9 pages
http://dx.doi.org/10.1155/2014/213239
Review Article

A Network Meta-Analysis on Randomized Trials Focusing on the Preventive Effect of Statins on Contrast-Induced Nephropathy

1Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100 Latina, Italy
2Department of Cardiovascular Sciences, European Hospital, 00149 Rome, Italy
3Department of Radiology, Copenhagen University Hospital, 2100 Herlev, Denmark
4Division of Cardiology, Policlinico Casilino, 00169 Rome, Italy
5Division of Cardiology, University of Turin, 10126 Turin, Italy
6Department of Cardiovascular, Respiratory, Nephrologic and Geriatric Sciences, Sapienza University of Rome, 00185 Rome, Italy
7VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, VA 23298, USA
8Department of Angiocardioneurology, IRCCS Neuromed, 86077 Pozzilli, Italy

Received 16 April 2014; Accepted 6 August 2014; Published 7 September 2014

Academic Editor: Emmanuel A. Burdmann

Copyright © 2014 Mariangela Peruzzi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Golshahi, H. Nasri, and M. Gharipour, “Contrast-induced nephropathy; A literature review,” Journal of Nephropathology, vol. 3, no. 2, pp. 51–56, 2014. View at Google Scholar
  2. T. Senoo, M. Motohiro, H. Kamihata et al., “Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome,” The American Journal of Cardiology, vol. 105, no. 5, pp. 624–628, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Wi, Y. G. Ko, J. S. Kim et al., “Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention,” Heart, vol. 97, no. 21, pp. 1753–1757, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Han, G. Zhu, L. Han et al., “Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease,” Journal of the American College of Cardiology, vol. 63, no. 1, pp. 62–70, 2013. View at Google Scholar
  5. S. N. Heyman, J. Reichman, and M. Brezis, “Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia,” Investigative Radiology, vol. 34, no. 11, pp. 685–691, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Farmer, “Pleiotropic effects of statins,” Current Atherosclerosis Reports, vol. 2, no. 3, pp. 208–217, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. M. H. Shishehbor, R. J. Aviles, M. Brennan et al., “Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy,” The Journal of the American Medical Association, vol. 289, no. 13, pp. 1675–1680, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Cao, P. Wang, K. Cui, L. Zhang, and Y. Hou, “Atorvastatin prevents contrast agent-induced renal injury in patients undergoing coronary angiography by inhibiting oxidative stress,” Nan Fang Yi Ke Da Xue Xue Bao, vol. 32, no. 11, pp. 1600–1602, 2012. View at Google Scholar · View at Scopus
  9. S. Jo, B. Koo, J. Park et al., “Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial—a randomized controlled study,” American Heart Journal, vol. 155, no. 3, pp. 499-e1–499-e8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. H. Jo, J. Y. Hahn, S. Y. Lee et al., “High-dose atorvastatin for preventing contrast-induced nephropathy in primary percutaneous coronary intervention,” Journal of Cardiovascular Medicine (Hagerstown), 2014. View at Publisher · View at Google Scholar
  11. A. Kaya, M. Kurt, I. H. Tanboğa et al., “Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-cIN trial),” Acta Cardiologica, vol. 68, no. 5, pp. 489–494, 2013. View at Google Scholar
  12. M. Leoncini, A. Toso, M. Maioli, F. Tropeano, S. Villani, and F. Bellandi, “Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: results from the PRATO-ACS study (protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome),” Journal of the American College of Cardiology, vol. 63, no. 1, pp. 71–79, 2014. View at Publisher · View at Google Scholar
  13. W. Li, X. Fu, Y. Wang et al., “Beneficial effects of high-dose atorvastatin pretreatment on renal function in patients with acute ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention,” Cardiology, vol. 122, no. 3, pp. 195–202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Li, X. Li, H. Ma et al., “Atorvastatin combining with probucol: a new way to reduce serum uric acid level during perioperative period of interventional procedure,” Scientific World Journal, vol. 2014, Article ID 565367, 6 pages, 2014. View at Publisher · View at Google Scholar
  15. H. Özhan, I. Erden, S. Ordu et al., “Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography,” Angiology, vol. 61, no. 7, pp. 711–714, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Patti, E. Ricottini, A. Nusca et al., “Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty—contrast-induced nephropathy] trial,” American Journal of Cardiology, vol. 108, no. 1, pp. 1–7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Quintavalle, D. Fiore, F. de Micco et al., “Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury,” Circulation, vol. 126, no. 25, pp. 3008–3016, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Toso, M. Maioli, M. Leoncini et al., “Usefulness of Atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease,” The American Journal of Cardiology, vol. 105, no. 3, pp. 288–292, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Xinwei, F. Xianghua, Z. Jing et al., “Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention,” The American Journal of Cardiology, vol. 104, no. 4, pp. 519–524, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Zhou, Y. Jin, Q. Wang, R. Min, and X. Zhang, “Efficacy of high dose atorvastatin on preventing contrast induced nephropathy in patients underwent coronary angiography,” Zhonghua Xin Xue Guan Bing Za Zhi, vol. 37, no. 5, pp. 394–396, 2009. View at Google Scholar · View at Scopus
  21. T. Greco, G. Landoni, G. Biondi-Zoccai et al., “A Bayesian network meta-analysis for binary outcome: how to do it,” Statistical Methods in Medical Research, 2013. View at Google Scholar
  22. F. D'Ascenzo and G. Biondi-Zoccai, “Network meta-analyses: the “White Whale” for cardiovascular specialists,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 28, no. 1, pp. 169–173, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Biondi-Zoccai, Network Meta-Analysis: Evidence Synthesis with Mixed Treatment Comparison, Nova Science Publishers, Hauppauge, NY, USA, 2014.
  24. G. G. L. Biondi-Zoccai, P. Agostoni, A. Abbate, L. Testa, F. Burzotta, and K. A. Robinson, “A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trials,” International Journal of Epidemiology, vol. 34, no. 1, pp. 224–225, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Biondi-Zoccai, M. Lotrionte, H. S. Thomsen et al., “Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysis,” International Journal of Cardiology, vol. 172, no. 2, pp. 375–80, 2014. View at Publisher · View at Google Scholar
  26. C. Haller and I. Hizoh, “The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro,” Investigative Radiology, vol. 39, no. 3, pp. 149–154, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Pisani, M. Sabbatini, E. Riccio et al., “Effect of a recombinant manganese superoxide dismutase on prevention of contrast-induced acute kidney injury,” Clinical and Experimental Nephrology, vol. 181, no. 3, pp. 424–431, 2013. View at Google Scholar
  28. J. G. Webb, G. E. Pate, K. H. Humphries et al., “A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect,” American Heart Journal, vol. 148, no. 3, pp. 422–429, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Khanal, N. Attallah, D. E. Smith et al., “Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions,” American Journal of Medicine, vol. 118, no. 8, pp. 843–849, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. R. E. Katholi, W. T. Woods Jr., G. J. Taylor et al., “Oxygen free radicals and contrast nephropathy,” American Journal of Kidney Diseases, vol. 32, no. 1, pp. 64–71, 1998. View at Publisher · View at Google Scholar · View at Scopus